Question 1

¿Es (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract seguro durante el embarazo?

Accepted Answer

The mixture includes Sophora flavescens (contains matrine/oxymatrine) for which developmental toxicity and neurodevelopmental effects were reported in zebrafish embryos and other preclinical models, and Carthamus tinctorius (safflower) has traditional/experimental evidence of uterotonic/abortifacient activity and developmental findings in animal models. These indicate suspected reproductive/developmental hazard (h=2) with a demonstrated mechanism in preclinical models (m=2). Topical cosmetic use implies low but measurable systemic exposure (e=1). Sources: PubMed developmental toxicity of matrine; safflower reproductive studies; CosIng/ECHA listings for the plant extracts.

Question 2

¿Es (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract seguro durante la lactancia?

Accepted Answer

Because the same plant extracts that drive the pregnancy concern (notably Sophora flavescens and safflower) have preclinical developmental/toxic activity, breastfeeding is conservatively scored the same hazard and mechanism (h=2, m=2). Systemic exposure via topical cosmetics is expected to be low (e=1); milk transfer data are not available but potential exists if systemic absorption occurs.

Question 3

¿Es (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract seguro para la piel del bebé?

Accepted Answer

Do not increase hazard or mechanism absent infant-specific toxicology, so h=2 and m=2 remain. Exposure (e) is increased by +1 for infant skin (immature barrier/higher surface-area-to-weight) from adult topical e=1 → baby e=2. There is limited infant-specific data on topical application of these extracts.

Question 4

¿Cómo puntúa VeriMom a (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract?

Accepted Answer

VeriMom puntúa (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract en 40/100 (riesgo medio) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.

Question 5

¿Cuáles son las alternativas seguras a (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract en el embarazo?

Accepted Answer

Consulta nuestra lista de alternativas seguras a (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract según función similar y clasificación sin riesgos conocidos.

(carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract

Datos Regulatorios

Sources & references

Alternativas seguras a (carthamus tinctorius/chamomilla recutita/syzygium aromaticum) flower/(lithospermum erythrorhizon/sophora flavescens/scutellaria baicalensis) root extract en el embarazo | VeriMom

Ingredientes — Ingredientes

Obtén el informe completo de seguridad en la app VeriMom